Article

Multiple rectal carcinomas successfully treated by intersphincteric resection with neoadjuvant therapy without radiation therapy: A case report

2022-10-26

Abstract excerpt

<h4>Background: </h4> In recent years, neoadjuvant chemoradiotherapy (NACRT) followed by total mesorectal resection has been the standard of care to prevent recurrence of locally advanced rectal cancer. However, radiotherapy is associated with several serious side effects in rectal cancer patients, including fecal incontinence, dysuria, sexual, dysfunction, and secondary cancer. Neoadjuvant chemotherapy (NAC) has...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2c5deb91-d342-5c37-9d04-6cda92e777ab
DOI: 10.21203/rs.3.rs-2189365/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multiple rectal carcinomas successfully treated by intersphincteric resection with neoadjuvant therapy without radiation therapy: A case reportDOI 10.21203/rs.3.rs-2189365/v1Read

Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: A case report and literature review.Semantic proximity Read

Rectal cancer.Semantic proximity Read

Clinical efficacy of intersphincteric resection for low rectal cancer compared with abdominoperineal resection: a single-center retrospective studySemantic proximity Read

Two cases of gastrointestinal tumor with uterine cervical metastases: a case reportSemantic proximity Read

Neoadjuvant Chemotherapy plus Bevacizumab Combined with Total Mesorectal Excision in Treating Locally Advanced Rectal Cancer Patients with BRAF Mutation: Clinical Benefit and Safety.Semantic proximity Read

Factors Affecting Survival Prognosis of Patients with Rectal Cancer After Neoadjuvant ChemoradiotherapySemantic proximity Read

The effects of chemoradiotherapy in IIA（T3N0M0）rectosigmoid junction cancer : a population-based studySemantic proximity Read

Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study).Semantic proximity Read

KRAS Mutant Status May Be Associated with Distant Recurrence in Early-stage Rectal Cancer.Semantic proximity Read

Tumor Resectability and Pathologic Response After Neoadjuvant Long-Course Chemoradiotherapy for Locally Advanced Rectal Cancer in a Resource-Limited SettingSemantic proximity Read

Synchronous Colorectal Carcinoma: Three Cases Report and Literature ReviewSemantic proximity Read

Assessing the practice of Total Neoadjuvant Therapy for rectal cancer: an online survey among Radiation Oncology Departments in Germany and German-Speaking Regions of Austria and SwitzerlandSemantic proximity Read